Kaliumjodide G.L. (Potassium Iodide)

Potassium iodide provides a stable source of iodide ions that quickly saturate the thyroid's sodium‑iodide symporter. This saturation blocks the gland from taking up additional iodine, including radioactive isotopes, thereby limiting radiation dose to the thyroid and preserving normal hormone synthesis.

The appropriate dose of Kaliumjodide G.L. is determined by a qualified prescriber based on the specific clinical scenario, such as the level of radioactive exposure or the degree of iodine deficiency. Healthcare professionals consider age, weight, renal function, and other factors when prescribing the exact amount.

Safety data for potassium iodide in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a healthcare professional familiar with the patient's medical history.

To order Kaliumjodide G.L., submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kaliumjodide G.L. is a pharmaceutical‑grade potassium iodide product, whereas many over‑the‑counter iodine supplements may contain variable concentrations of iodide or different chemical forms. The pharmaceutical preparation offers precise dosing, regulatory compliance and documented efficacy for thyroid blocking, making it the preferred choice for radiation‑protection protocols.

Kaliumjodide G.L. should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. No special refrigeration is required for this oral formulation.

Kaliumjodide G.L. is taken orally, usually with a glass of water. The tablet or capsule should be swallowed whole unless the prescriber advises otherwise. Administration timing depends on the clinical indication, such as before anticipated radioactive iodine exposure or as directed for iodine supplementation.

Serious risks include severe allergic reactions (e.g., anaphylaxis), significant thyroid dysfunction such as hypothyroidism or hyperthyroidism, and iodide‑induced thyroiditis. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, swelling of the face or neck, rapid heart rate, or unexplained changes in temperature tolerance.

Kaliumjodide G.L. should be avoided in individuals with known hypersensitivity to potassium iodide or any excipients in the formulation. It is also contraindicated in patients with certain thyroid disorders, such as untreated hyperthyroidism, unless supervised by an endocrinologist, and in those taking medications that could cause harmful iodide interactions without proper monitoring.